Most Long COVID studies have focused on either survey data or medical records, with very few studies having used insurer claims data to date. Even fewer studies have focused on the commercially insured population. This study does both by using a unique dataset of commercial claims which allows us to analyze the effects of a COVID-19 diagnosis on future claims cost and conditions.
